呼吸モニタリング機器の世界市場-2023年～2030年

市場概要

呼吸モニタリング機器の世界市場は、2022年に46億米ドルに達し、2030年には93億米ドルに達することで有利な成長が予測されています。世界の呼吸モニタリング機器市場は、予測期間2023-2030年にCAGR 9.3%を示すと予測されています。

呼吸モニタリング機器は、気道の規則的な動作と酸素供給を評価します。呼吸ガスの交換における肺の有効性を評価し、気道の閉塞を発見するために、いくつかの呼吸器検査が開発されています。呼吸モニタリング機器の売上は、呼吸モニタリング機器市場の拡大に利用されます。

呼吸モニタリング機器は呼吸に関するパラメーターを追跡し、呼吸器疾患の診断に役立っています。大気汚染の拡大、呼吸器疾患の症例、高齢者人口、市場開拓が世界の呼吸モニタリング機器市場を促進します。

市場力学

老人人口の増加

老人人口の増加は、予測期間における市場成長を促進する重要な要因の1つです。高齢者人口の増加は、呼吸モニタリング機器の使用が不可欠であるこの年齢で、人の免疫システムが弱くなるため、呼吸モニタリング機器の増加につながりました。

例えば、NCBIに掲載された論文によると、喫煙者であること、アルコール依存症であること、ポリファーマシー、追加の併存疾患の存在は、呼吸器疾患に感染した高齢者の治療結果に影響を与える要因であり、実際に呼吸器モニタリングデバイスが必要とされ、将来の市場成長に貢献しています。

ヘルスケア支出の増加

呼吸ケア機器市場は、先進国や新興国におけるヘルスケア支出の増加によって牽引されています。これは、これらの国の政府がヘルスケア施設の質を高めるために支出を行っているためです。さらに、主に政府の取り組み強化により、新興国での1人当たりヘルスケア支出が増加していることなどが、治療の手ごろさとアクセシビリティを高め、市場拡大を後押ししています。

例えば、国際呼吸器学会フォーラム（Forum of International Respiratory Societies）によると、喘息とCOPDは年間約48万9,000人、1日当たり1,300人以上が死亡し、世界中で2億人以上が影響を受け、6,500万人が中等度または重度の気道疾患を抱えています。その結果、慢性閉塞性肺疾患や喘息などの呼吸器疾患の有病率が上昇し、市場を前進させています。

呼吸モニタリング機器の認知不足

市場成長の抑制要因の1つは、呼吸モニタリング機器の認知度の低さです。機器の情報不足と利用不足は市場成長の低下につながります。

このような装置の存在を知らない個人や、呼吸器疾患の初期徴候や症状、あるいは呼吸器の健康状態を監視する必要性を認識できないなど、多くの条件が市場に影響を及ぼします。そのため、医療機関を受診するのが遅れ、診断や治療の遅れにつながります。

COVID-19影響分析

世界のCOVID-19症例の増加に伴い、パルスオキシメーター、人工呼吸器、スパイロメーターなどの呼吸モニタリング機器の必要性が急増しています。これらの機器は、酸素飽和度レベル、肺機能のモニタリング、急性呼吸困難に陥った患者の呼吸補助に不可欠です。サプライチェーンの問題も一因となっており、呼吸モニタリング機器の需要増は世界のサプライチェーンに負担をかけています。

ロシア・ウクライナ紛争影響分析

ロシアとウクライナの紛争は、この地域の主要市場プレーヤーの数が少ないため、世界の呼吸モニタリング機器市場に与える影響は中程度と推定されます。しかし、原材料の輸出入の影響は、予測期間中、世界の呼吸モニタリング機器市場の成長にほとんど影響を与えないと予測されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 呼吸器疾患の増加
    • 技術の進歩
  • 抑制要因
    • 承認プロセスの長期化
  • 機会
    • 新興市場の主要企業による投資
  • 影響分析

第5章 産業分析

• ポーターの5フォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 COVID-19分析

第7章 製品別

• スパイロメーター
• ピークフローメーター
• 睡眠検査装置
• ガス分析器
• パルスオキシメーター
• カプノグラフィー
• その他

第8章 エンドユーザー別

• 病院
• 外来手術センター
• 在宅医療
• その他

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • その他アジア太平洋地域
• 中東およびアフリカ
  • 主な地域別ダイナミクス

第10章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第11章 企業プロファイル

• GE Healthcare
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Smith & Nephew
• Vyaire（Carefusion Corporation）
• Masimo Corporation
• Medtronic plc
• MGC Diagnostics Corporation
• COSMED
• Nihon Kohden Corporation
• Philips Healthcare
• Novelda AS

第12章 付録

Market Overview

The Global Respiratory Monitoring Devices Market reached US$ 4.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 9.3 billion by 2030. The global respiratory monitoring devices market is expected to exhibit a CAGR of 9.3% during the forecast period 2023-2030.

A Respiratory Monitoring Device Evaluates the airways' regular operation and oxygen delivery. Several respiratory tests are being developed to evaluate the efficacy of the lungs in exchanging breathing gases and finding respiratory tract blockages. Sales of respiratory monitoring devices are used to augment the respiratory monitoring device market.

Respiratory Monitoring Devices track parameters related to breathing, which help diagnose respiratory illnesses. The growing air pollution, cases of respiratory disorders, geriatric population, and market developments promote the global respiratory monitoring devices market.

Market Dynamics

Rise in Geriatric Population

The rise in the geriatric population is one of the significant drivers that drive the market growth in the forecast period. The rise in the population of older people led to increasing the respiratory monitoring devices since the immune system of a person gets weak at this age where the requirement of respiratory monitoring devices is essential to use, which indeed helps the market to grow during the forecast period.

For instance, according to the article published in NCBI, being a smoker, an alcoholic, polypharmacy, and the presence of additional co-morbidities were factors that affected the treatment results of older adults infected with respiratory diseases which indeed needed respiratory monitoring devices that helps the market to grow in future.

Increasing Healthcare Expenditure

The respiratory care devices market is driven by rising healthcare expenditures in developed and developing nations. This is due to those nations' governments are spending in enhancing the quality of healthcare facilities. Furthermore, factors such as rising healthcare spending per capita in emerging nations, mainly due to increased government initiatives, will likely boost treatment affordability and accessibility, aiding market expansion.

For instance, according to the Forum of International Respiratory Societies, Asthma and COPD cause around 489,000 fatalities per year, or more than 1300 deaths per day, and impact more than 200 million people worldwide, with 65 million having moderate or severe airway disease. As a result, the rising prevalence of respiratory disorders such as chronic obstructive pulmonary disease and asthma is propelling the market forward.

Lack of Awareness of Respiratory Monitoring Devices

One of the restraints to market growth is a lack of awareness of respiratory monitoring devices. The lack of information and utilization of the devices will lead to a reduction in market growth.

Many conditions affect the market, including individuals unaware of these devices and failing to recognize the early signs and symptoms of respiratory disorders or the need to monitor their respiratory health. This causes delays in seeking medical attention, leading to delayed diagnosis and treatment.

COVID-19 Impact Analysis

With the growth of COVID-19 cases worldwide, the need for respiratory monitoring devices, including pulse oximeters, ventilators, and spirometers, has skyrocketed. These devices are critical for monitoring oxygen saturation levels, lung function, and respiratory assistance to patients suffering from acute respiratory distress. Supply chain issues have also been a factor, with growing demand for respiratory monitoring equipment putting strain on the worldwide supply chain.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global respiratory monitoring devices market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global respiratory monitoring devices market growth over the forecast period.

Segment Analysis

The Global Respiratory Monitoring Devices Market is segmented based on product, end user and region.

The Peak Flow Meters Product Segment Accounted for Approximately 24.9% of the Respiratory Monitoring Devices Market Share

The peak flow meter devices are used to measure the rate of breathing. Peak flow meters that are lightweight, simple to handle and transport, and remotely accessible are in high demand. For instance, On April 18 2023, Tenovi has introduced a cellular FDA-cleared remote peak flow meter (PFM) for advanced remote physiological monitoring of asthmatic patients.

When combined with Tenovi's cellular gateway, the device allows patients with asthma to transmit peak expiratory flow rate (PEF) and 1-second forced expiratory volume (fev1) readings instantly to clinicians. Asthma is a chronic respiratory condition that affects millions of people worldwide, and effective monitoring of asthmatic symptoms is essential for proper management.

Geographical Analysis

North America Accounted for Approximately 39.5% of the Market Share Owing to the Strong Presence of Major Players.

North America is estimated to hold about 39.5% of the total market share throughout the forecast period. The dominating market, such as the United States, is distinguished by increased healthcare expenditures, robust healthcare infrastructure, and enhanced access to healthcare services.

The average per capita healthcare spending in the United States was $40,624 in 2022. Furthermore, rising public awareness of the many sophisticated respiratory monitoring equipment has aided North American respiratory monitoring devices' growth.

Competitive Landscape

The major global players in respiratory monitoring devices include: GE Healthcare, Smith & Nephew, Vyaire (CareFusion Corporation), Masimo Corporation, Medtronic, MGC Diagnostics Corporation, COSMEDN, Nihon Kohden Corporation, Philips Healthcare, and Novelda AS, among others.

Why Purchase the Report?

• To visualize the Global Respiratory Monitoring Devices Market segmentation based on product, end user and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of respiratory monitoring devices market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The Global Respiratory Monitoring Devices Market Report Would Provide Approximately 53 Tables, 54 Figures And 195 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product
• 3.2. Snippet by End User
• 3.3. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Prevalence of Respiratory Diseases
    • 4.1.1.2. Rise in Technological Advancements
  • 4.1.2. Restraints
    • 4.1.2.1. Longer Duration of Approval Process
  • 4.1.3. Opportunity
    • 4.1.3.1. Investment by key players in emerging markets
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's 5 Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID-19
  • 6.1.2. Scenario During COVID-19
  • 6.1.3. Scenario Post COVID-19
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 7.1.2. Market Attractiveness Index, By Product
• 7.2. Spirometer *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Peak Flow Meters
• 7.4. Sleep Test Devices
• 7.5. Gas Analyzers
• 7.6. Pulse Oximeters
• 7.7. Capnography
• 7.8. Others

8. By End User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.1.2. Market Attractiveness Index, By End User
• 8.2. Hospitals *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Ambulatory Surgery Centers
• 8.4. Homecare
• 8.5. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.5.1. The U.S.
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.5.1. Germany
    • 9.3.5.2. The U.K.
    • 9.3.5.3. France
    • 9.3.5.4. Spain
    • 9.3.5.5. Italy
    • 9.3.5.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.5.1. Brazil
    • 9.4.5.2. Argentina
    • 9.4.5.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.5.1. China
    • 9.5.5.2. India
    • 9.5.5.3. Japan

Australia

• 9.5.5.4. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. GE Healthcare *
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Smith & Nephew
• 11.3. Vyaire (Carefusion Corporation)
• 11.4. Masimo Corporation
• 11.5. Medtronic plc
• 11.6. MGC Diagnostics Corporation
• 11.7. COSMED
• 11.8. Nihon Kohden Corporation
• 11.9. Philips Healthcare
• 11.10. Novelda AS

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us